In this article, we will be taking a look at the 5 best humane stocks to buy now. To see more such stocks click 10 Best humane Stocks to Buy Now.
5. Beyond Meat Inc. (NASDAQ:BYND)
Market Capitalization as of April 13: $949.88 million
Number of Hedge Fund Holders: 13
Beyond Meat Inc. (NASDAQ:BYND) is a company that produces plant-based meat alternatives. The company is dedicated to sustainability and minimizing the adverse environmental effects associated with animal agriculture. Beyond Meat Inc. (NASDAQ:BYND) claims that its products use less water, land, and energy than traditional meat production and generate fewer greenhouse gas emissions.
Beyond Meat Inc. (NASDAQ:BYND) promotes animal welfare by providing plant-based meat alternatives that reduce the demand for traditional animal-based meat. They support local communities by sourcing ingredients from local farmers and lowering their own environmental impact. Beyond Meat Inc. (NASDAQ:BYND) also partners with organizations like the ASPCA and The Humane Society to support animal welfare in the food industry.
Horos Asset Management mentioned Beyond Meat Inc. (NASDAQ:BYND) in its Q1 2022 investor letter. Here is what the fund said:
“What about the other asset class that has attracted the most attention from the investment community in recent times? Beyond Meat is the other company whose valuations we did not understand and whose share price has also declined drastically in the last year and a half.”
Follow Beyond Meat Inc. (NYSE:BYND)
Follow Beyond Meat Inc. (NYSE:BYND)
4. Agilon Health Inc. (NYSE:AGL)
Market Capitalization as of April 13: $11.71 billion
Number of Hedge Fund Holders: 15
Agilon Health Inc. (NYSE:AGL) is a healthcare services provider for seniors in the United States through primary care physicians. The company served about 269,500 medicare advantage members and 89,000 Medicare fee-for-service beneficiaries as of December 31, 2022. Agilon Health Inc. (NYSE:AGL) ranks second on our list of 10 best Humane stocks to buy now.
In August, Agilon Health Inc. (NYSE:AGL) released its inaugural Total Care, Healthier Communities Impact Report, which outlines the company’s ESG performance for 2021. The report provides an enterprise-wide analysis of the company’s ESG actions, programs, and investments, focusing on creating a sustainable value-based primary care model that transforms healthcare in over 100 communities. Agilon Health Inc. (NYSE:AGL) empowers physicians to focus on the total health of their senior patients and invests in its physician partners and communities to improve the quality of care for seniors.
Wells Fargo analyst Stephen Baxter raised the price target of Agilon Health Inc. (NYSE:AGL) to $28 from $22 and maintained an ‘Overweight’ rating on the shares on March 16. The analyst commented that 2024 expectations were better-than-feared, despite the possible obstacles from proposed MA rates and risk model changes.
There were 15 hedge funds in our database that held stakes in Agilon Health Inc. (NYSE:AGL)’s at the end of the fourth quarter, compared to 19 funds in Q3 2022. The company’s most notable stakeholder is Durable Capital Partners, with 8.84 million shares worth $142.72 million.
Follow Agilon Health Inc.
Follow Agilon Health Inc.
3. Oatly Group AB – ADR (NASDAQ:OTLY)
Market Capitalization as of April 13: $1.34 billion
Number of Hedge Fund Holders: 15
Oatly Group AB – ADR (NASDAQ:OTLY) is a Swedish company that produces plant-based dairy products made from oats. They demonstrate their commitment to sustainability by striving to lower greenhouse gas emissions, practicing responsible use of natural resources, and phasing out the use of fossil fuels. Oatly Group AB – ADR (NASDAQ:OTLY) is placed fourth on our list of 10 best humane stocks to buy now.
Oatly Group AB – ADR (NASDAQ:OTLY) has worked towards eight UN Sustainable Development Goals. They aim to drive more sustainable practices in their supply chain, particularly in areas such as oats, suppliers, and packaging. Despite a 77% increase in their corporate climate footprint from 2020 to 2021, Oatly strives to reduce emissions through low-emission practices.
Here is what ClearBridge Investments Mid Cap Growth Strategy has to say about Oatly Group AB (NASDAQ:OTLY) in its Q4 2021 investor letter:
“We also closed out three names as we constantly seek ways to improve the Strategy’s overall growth profile. Oatly is a leader in dairy alternative oat-milk products benefiting from long-term secular growth of the category. That growth, however, is contingent on its ability to scale up manufacturing and we sold the position due to increased risk that global supply chain constraints would limit such efforts.”
Follow Oatly Group Ab (NASDAQ:OTLY)
Follow Oatly Group Ab (NASDAQ:OTLY)
2. Ingredion Inc. (NYSE:INGR)
Market Capitalization as of April 13: $6.95 billion
Number of Hedge Fund Holders: 28
Ingredion Inc. (NYSE:INGR), a global provider of specialty ingredient solutions to the food and beverage industry, is advancing its sustainability initiatives in the Asia Pacific region. The company is working towards aligning with the United Nations Sustainable Development Goals under the 2030 All Life plan, with the goal of having 99% of all crops and 100% of its Tier 1 crops sustainably sourced by 2025.
Ingredion Inc. (NYSE:INGR)’s Shandong South production facility in China sources non-GMO corn from local farmers to create corn-based native and modified starch products. Additionally, the company’s research into stevia shows it has the potential for sustainable sugar reduction. Ingredion Inc. (NYSE:INGR) will make available the environmental and human impact of 50 of its strategic growth platform ingredients to the industry via HowGood by the end of 2022.
On February 2, Credit Suisse raised Ingredion Inc. (NYSE: INGR)’s price target to $110 from $100 and retained a ‘Neutral’ rating. They noted significant improvement in the company’s execution and industry backdrop for sweeteners and starches after a period of volatility.
At the end of December 2022, 28 hedge funds in Insider Monkey’s database had stakes in Ingredion Inc. (NYSE:INGR), compared with 27 in the previous quarter. The consolidated value of these stakes is over $512.9 million. Yacktman Asset Management is Ingredion Inc. (NYSE:INGR)’s notable stakeholder in Q4 2022.
Follow Ingredion Inc (NYSE:INGR)
Follow Ingredion Inc (NYSE:INGR)
1. Colgate-Palmolive Company (NYSE:CL)
Market Capitalization as of April 13: $63.24 billion
Number of Hedge Fund Holders: 61
Colgate-Palmolive Company (NYSE:CL) is a global company that is dedicated to sustainability and social impact. They offer products in oral care, personal care, home care, and pet nutrition in more than 200 countries. Colgate-Palmolive Company (NYSE:CL) has made significant progress in reducing plastic waste, conserving natural resources, and improving children’s oral health through its Bright Smiles, Bright Futures program.
In their 2021 Sustainability & Social Impact Report, Colgate-Palmolive Company (NYSE:CL) outlined their advancements towards their ambitious sustainability goals, including their Climate Action & Net Zero Carbon transition and targets. The company aims to reduce emissions by 20% by 2025, 42% by 2030, and reach Net Zero carbon emissions across the value chain by 2040. Colgate-Palmolive Company (NYSE:CL) is also committed to creating a more inclusive world and helping children, their families, and communities thrive through their enhanced ambition for Driving Social Impact.
The number of hedge funds tracked by Insider Monkey having stakes in Colgate-Palmolive Company (NYSE:CL) increased to 61 in Q4 from 57 in the preceding quarter. These stakes hold a consolidated value of $4.46 billion. Dan Loeb’s Third Point is a significant shareholder in the company, with 11.55 million shares valued at $910.02 million.
In its Q4 2022 investor letter, Third Point mentioned Colgate-Palmolive Company (NYSE:CL). Here‘s what the company has to say:
“Colgate-Palmolive Company (NYSE:CL) remains one of the firm’s largest equity positions. The company offers defensive growth at a reasonable valuation, and we continue to see the potential for shares to deliver attractive risk adjusted returns over the next several years.
Fourth Quarter results were disappointing. The company missed on gross margins, guided 2023 well below the Street, and took another large impairment charge on its portfolio of skin care brands. The price action on the day of the print (down 5%) was extreme and perhaps reflective of growing investor frustration that the company has failed to sustainably grow earnings over the past decade.”
Follow Colgate Palmolive Co (NYSE:CL)
Follow Colgate Palmolive Co (NYSE:CL)
Insider Monkey focuses on uncovering the best investment ideas of hedge funds and insiders. Please subscribe to our free daily newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below. You can also check out our articles on 10 Best EV Battery Stocks Under $10 and 12 Best Dow Stocks To Buy Right Now.